X0306 4/A 2021-07-29 2021-08-02 0 0001841387 Candel Therapeutics, Inc. CADL 0001494695 Manning Paul B C/O CANDEL THERAPEUTICS, INC. 117 KENDRICK ST., SUITE 450 NEEDHAM MA 02494 1 0 1 0 Common Stock 2021-07-29 4 C 0 679158 A 679158 I By Paul B. Manning Revocable Trust Common Stock 2021-07-29 4 C 0 553752 A 553752 I By BKB Growth Investments, LLC Common Stock 2021-07-29 4 P 0 1625000 8.00 A 1681000 D Series B Preferred Stock 2021-07-29 4 C 0 1669303 0.00 D Common Stock 679158 0 I By Paul B. Manning Revocable Trust Series B Preferred Stock 2021-07-29 4 C 0 1361069 0.00 D Common Stock 553752 0 I By BKB Growth Investments, LLC These shares of Series B Preferred Stock were convertible at any time at the holder's election and automatically converted on a one-for-2.4579 basis into shares of the Issuer's common stock immediately upon the closing of the Issuer's initial public offering ("IPO") without payment of additional consideration. The Series B Preferred Stock had no expiration date. The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein. Includes shares held jointly with spouse. This Form 4 amends and restates the Form 4 filed by the Reporting Person on August 2, 2021 to include inadvertently omitted shares purchased in the initial public offering by the Reporting Person. /s/ John Canepa, Attorney-in-Fact 2021-08-04